Search
Cyproheptadine H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175075Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Protein kinase C alpha typeHydroxyzine H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175076Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Protein kinase C alpha typeAzatadine H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175078Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Protein kinase C alpha typePhenindamine H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175090Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Protein kinase C alpha typeMethapyrilene H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175092Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Protein kinase C alpha typeDexchlorpheniramine H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175102Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Protein kinase C alpha typeChlorcyclizine H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175115Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Protein kinase C alpha typeButriptyline H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175155Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Protein kinase C alpha typeEbastine H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175100Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Protein kinase C alpha typeDeptropine H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175120Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Protein kinase C alpha type